News + Font Resize -

Approvable letter issued for Ambien CR for treatment of insomnia
Paris | Tuesday, April 12, 2005, 08:00 Hrs  [IST]

Sanofi-aventis has received an approvable letter from the US Food and Drug Administration (FDA) for Ambien CR (zolpidem tartrate extended release) CIV. Ambien CR is the controlled-release formulation of zolpidem, the world's leading sleep aid.

Post Your Comment

 

Enquiry Form